Monsanto Company (MON): Bet On the Bully!

Page 1 of 2

Monsanto Company (NYSE:MON) has always been one of the most controversial and intriguing stocks in the market. Although seeds have been patented since the 1930s, Monsanto’s size and dominance of the genetically-engineered, herbicide-resistant seeds market has raised a serious question — should life be patented?

A farmer from Indiana recently squared off with Monsanto in the Supreme Court, challenging the company’s assertion that second-generation seeds from its genetically engineered ones are also protected under existing patents. Just how far do Monsanto’s patents extend, and why are they so critical for the company’s survival? Does the company’s apparent stranglehold on the country’s farming industry also mean that it is a solid investment, despite lingering ethical issues? Let’s take a look at how Monsanto operates.

genetically modified foodsA Simple Business Model

Monsanto Company (NYSE:MON)’s business model is fairly easy to understand. First, it produces Roundup, an herbicide also known as glyphosate. Second, it manufactures genetically altered seeds (soybean, corn, sorghum and others), labeled as Roundup Ready, that are specifically designed to be immune to Roundup, and not other herbicides.

Monsanto’s straightforward strategy is to dominate both businesses by introducing farmers to one product, which is paired with the other. That simple strategy has pushed its seeds into 90% of the United States soybean farms since the first seed was introduced in 1996. Farmers can choose to buy new seeds from Monsanto every year, but Monsanto restricts them from collecting second-generation seeds, which the company claims are patented technology.

Monsanto has repeatedly sued individual farmers accused of hoarding second-generation seeds to avoid paying Monsanto for new ones. It has even gone as far as to research self-terminating seeds, which become infertile after their first generation. However, the company has never commercially released these seeds, and does not plan to do so in the future.

David vs. Goliath

Vernon Hugh Bowman, a 75-year-old farmer from Indiana, recently clashed with Monsanto in the Supreme Court after the company accused him of violating its patents by knowingly planting second-generation Monsanto seeds. Throughout most of his career, Bowman had been a loyal Monsanto customer, purchasing its engineered soybean seeds every year and signing an agreement that prohibited him from gathering or planting second-generation seeds.

However, during the off-season, Bowman purchased additional seeds from a crop elevator, which consists of “junk” seeds usually used for animal feed. Bowman identified and separated the second-generation Monsanto seeds and planted them. For this violation, Monsanto is seeking $84,000 in damages from Bowman.

Similar cases have occurred in the past, where second-generation Monsanto seeds were blown into neighboring non-Monsanto farm’s fields. Monsanto sued those farmers as well for patent violations.

Goliath crushes David

In the Bowman case, the Supreme Court sided with Monsanto, crushing hopes that a small-town farmer would be David to Monsanto’s Goliath.

Chief Justice John Roberts defended the company, claiming, “Why in the world would anybody spend any money to try to improve the seed if as soon as they sold the first one anybody could grow more and have as many of those seeds as they want?”

Monsanto’s critics have often claimed that no company should ever be allowed to patent nature, while its supporters have compared the unauthorized creation of second-generation Monsanto crops to software, movie or music piracy. Purchasing a single copy of a patented or copyrighted product doesn’t give a consumer the right to reproduce the product and sell it for a profit.

Page 1 of 2

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click Here to Read Comments
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!